Elizabeth Yeu Lin net worth and biography

Elizabeth Lin Biography and Net Worth

Director of Tarsus Pharmaceuticals

Elizabeth (Liz) has more than 20 years of clinical ophthalmology and eye care leadership experience. Prior to becoming CMO, Liz served as Tarsus’ Chief Medical Advisor since 2020 and as a Board member since 2021.

Liz has authored hundreds of publications, is a renowned speaker on key topics in eye care and serves on several national medical boards and committees, including as an examiner for the American Board of Ophthalmology and as the Chair of the Refractive Surgery Section of the Annual Meeting Program Committee for the American Academy of Ophthalmology (AAO). She is the immediate Past President of the American Society of Cataract and Refractive Surgery (ASCRS) and is a partner at Virginia Eye Consultants, where she continues her clinical practice.

Liz earned her medical degree through a seven-year combined undergraduate and medical school honors program from the University of Florida College of Medicine and completed her ophthalmology residency at Rush University Medical Center, where she served as Chief Resident. She completed her fellowship at Baylor College of Medicine’s Cullen Eye Institute, where she also served as an Assistant Professor. She continues to train residents as Assistant Professor of Ophthalmology at Eastern Virginia Medical School.

What is Elizabeth Yeu Lin's net worth?: The estimated net worth of Elizabeth Yeu Lin is at least $137,296.95 as of September 21st, 2023. Lin owns 2,855 shares of Tarsus Pharmaceuticals stock worth more than $137,297 as of March 15th. This net worth estimate does not reflect any other investments that Lin may own. Additionally, Lin receives an annual salary of $59,120.00 as Director at Tarsus Pharmaceuticals. Learn More about Elizabeth Yeu Lin's net worth.
How old is Elizabeth Yeu Lin?: Lin is currently 46 years old. There are 3 older executives and no younger executives at Tarsus Pharmaceuticals. The oldest executive at Tarsus Pharmaceuticals is Mr. Jeffrey S. Farrow, CFO & Chief Strategy Officer, who is 62 years old. Learn More on Elizabeth Yeu Lin's age.
What is Elizabeth Yeu Lin's salary?: As the Director of Tarsus Pharmaceuticals, Inc., Lin earns $59,120.00 per year. There are 4 executives that earn more than Lin. The highest earning executive at Tarsus Pharmaceuticals is Dr. Seshadri Neervannan Ph.D., Chief Operating Officer, who commands a salary of $759,200.00 per year. Learn More on Elizabeth Yeu Lin's salary.
How do I contact Elizabeth Yeu Lin?: The corporate mailing address for Lin and other Tarsus Pharmaceuticals executives is , , . Tarsus Pharmaceuticals can also be reached via phone at 949-409-9820 and via email at ir@tarsusrx.com. Learn More on Elizabeth Yeu Lin's contact information.
Has Elizabeth Yeu Lin been buying or selling shares of Tarsus Pharmaceuticals?: Elizabeth Yeu Lin has not been actively trading shares of Tarsus Pharmaceuticals during the last ninety days. Most recently, on Tuesday, August 15th, Elizabeth Yeu Lin bought 9,506 shares of Tarsus Pharmaceuticals stock. The stock was acquired at an average cost of $16.80 per share, with a total value of $159,700.80. Following the completion of the transaction, the director now directly owns 15,866 shares of the company's stock, valued at $266,548.80. Learn More on Elizabeth Yeu Lin's trading history.
Who are Tarsus Pharmaceuticals' active insiders?: Tarsus Pharmaceuticals' insider roster includes D. Ackermann (Director), Bobak Azamian (CEO), Andrew Goldberg (Director), Leonard Greenstein (CFO), Elizabeth Lin (Director), Aziz Mottiwala (Insider), Seshadri Neervannan (COO), Bryan Wahl (General Counsel), and Dianne Whitfield (Chief Human Resources Officer). Learn More on Tarsus Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Tarsus Pharmaceuticals?: During the last year, insiders at the sold shares 4 times. They sold a total of 24,496 shares worth more than $749,577.60. The most recent insider tranaction occured on March, 18th when insider Aziz Mottiwala sold 4,766 shares worth more than $145,839.60. Insiders at Tarsus Pharmaceuticals own 8.3% of the company. Learn More about insider trades at Tarsus Pharmaceuticals.
Information on this page was last updated on 3/18/2024.

Elizabeth Yeu Lin Insider Trading History at Tarsus Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/15/2023	Buy	9,506	$16.80	$159,700.80	15,866
9/14/2022	Buy	18,400	$16.12	$296,608.00	12,040

Elizabeth Yeu Lin Buying and Selling Activity at Tarsus Pharmaceuticals

Tarsus Pharmaceuticals Company Overview

Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

Today's Range

Now: $48.09

$45.60

$48.23

50 Day Range

MA: $49.11

$41.29

$56.94

2 Week Range

Now: $48.09

$20.08

$57.28

Volume

487,715 shs

Average Volume

639,551 shs

Market Capitalization

$1.85 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.05

Elizabeth Lin Biography and Net Worth

What is Elizabeth Yeu Lin's net worth?

How old is Elizabeth Yeu Lin?

What is Elizabeth Yeu Lin's salary?

How do I contact Elizabeth Yeu Lin?

Has Elizabeth Yeu Lin been buying or selling shares of Tarsus Pharmaceuticals?

Who are Tarsus Pharmaceuticals' active insiders?

Are insiders buying or selling shares of Tarsus Pharmaceuticals?